This issue of International Journal of Urology contains two Review Articles, 13 Original Articles, three Urological Notes, nine Editorial Comments, one Letter to the Editor, and three Author's Replies. Prostate biopsy is one of the most frequently performed urological procedures. Despite being generally safe and well-tolerated, it is sometimes associated with complications including acute bacterial prostatitis especially in transrectal approach. In the last decade, an increased number of fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing Escherichia coli have been reported in cases of acute prostatitis. In the Review Article by Acosta et al. (Okayama, Japan), the authors emphasized the clinical value of the isolation of these pathogens from rectal bio-flora samples, which can be easily obtained through the fingertip of a sterile glove or a cotton swab, with selective media before transrectal prostate biopsy. As the authors described, this preventive measure may allow us to offer a tailored prophylactic treatment that benefits patients and reduces the economic burden for the hospital. The treatment paradigm for metastatic renal cell carcinoma (mRCC) has been dramatically changed by the introduction of immune checkpoint inhibitors (ICIs). Recent clinical trials have demonstrated the survival advantages of several kinds of the first-line ICI combination therapy compared with sunitinib, suggesting that substantial improvements in survival for patients with mRCC could be achieved during the ICI era compared with the tyrosine kinase inhibitor (TKI) era. Besides the advancement of systemic anticancer therapy, surgical resection of the primary tumor or metastases remains an important option in the management of mRCC although the clinical implications of these surgeries have changed in the TKI era. In the Review Article by Naito et al. (Yamagata, Japan), the authors provided an excellent overview about cytoreductive nephrectomy, metastatectomy, and radiotherapy for metastatic lesions in the ICI era. At present, this topic has minimal evidence and further investigations are needed. This review will give some hints to the readers for tomorrow's practice. A difficult ureter (DU) is defined as a ureter that requires prestenting because a ureteroscope or a ureteral access sheath needed for treatment cannot be inserted during retrograde intervention. In the Original Article by Waseda et al. (Tokyo, Japan), the authors focused on risk factors and predictive models for ureteral difficulty during retrograde ureteroscopic lithotripsy in clinical practice. It is meaningful and important to predict DU prior to surgery because the presence or absence of DU is related to the success of the procedure. Interestingly, the absence of stone history was the greatest risk factor for developing DU, followed by age 45 years or younger and renal stones only. As the authors suggested, preoperative assessment of the risk of DU may be helpful in the informed consent for patients requiring retrograde lithotripsy. Surgical resection of RCC with inferior vena cava (IVC)–tumor thrombus (TT) is the standard of care for nonmetastatic patients and confers long-term survival. However, it is a technically challenging procedure with a high risk of morbidity (40–50%) and mortality (5–10%). One of the serious complications is intraoperative tumor embolism (iTE) of pulmonary artery. Currently, there is no consensus on whether it is optimal to perform thrombectomy before kidney mobilization (“thrombus first”) or vice versa (“thrombus last”). In the Original Article by Ishiyama et al. (Tokyo, Japan), the authors compared these two techniques focusing on iTE prevalence and other early surgical outcomes in 130 patients with RCC and IVC-TT. In this retrospective study, there were four cases (3.1%) of iTE, all from the thrombus-last group. Additionally, those who underwent the thrombus-first technique experienced shorter operation time, smaller estimated blood loss, fewer complications, and shorter in-hospital stay. “Thrombus-first” approach may be preferred when performing nephrectomy and caval thrombectomy under open procedures. Unfortunately, the limited space does not allow me to introduce all the articles. However, all the papers are interesting, informative, and well-illustrated. I hope you enjoy this issue of International Journal of Urology. None declared.